Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 22 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
12(70.6%)
Phase 2
5(29.4%)
17Total
N/A(12)
Phase 2(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (22)

Showing 20 of 22 trials
NCT05913180Phase 2Recruiting

Vitamin C Effectiveness in Preventing Urinary Tract Infections After Gynecological Surgeries

Role: collaborator

NCT07162974Not ApplicableCompleted

Litholytic Therapy for Coral Urate Nephrolithiasis

Role: lead

NCT05230628Not ApplicableActive Not Recruiting

Auricular Vagus Stimulation in Obesity

Role: collaborator

NCT04656028Not ApplicableActive Not Recruiting

Genetic Testing and Motivational Counseling for FH

Role: collaborator

NCT06541236Not ApplicableRecruiting

Alveolar Ridge Preservation After Tooth Extraction Using Autologous Dentin Matrix

Role: lead

NCT04898140Completed

The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents

Role: collaborator

NCT05007691Not ApplicableUnknown

Comparative Study of Maxillary and Mandibular Splints Used for the Treatment of Masticatory Muscle Parafunction (FEA)

Role: lead

NCT05277662Not ApplicableUnknown

Precision Diagnostics of Functional and Organic Intestinal Pathology Based on Cellular and Molecular Profiling

Role: lead

NCT05132309Completed

Intestinal Microbiota Composition in Patients With Chronic Pancreatitis and Pancreatic Exocrine Insufficiency

Role: collaborator

NCT05134077Not ApplicableUnknown

Influence of Simple Renal Cysts on Renal Function

Role: lead

NCT05094947Not ApplicableUnknown

Intermittent Catheterization Versus Trial Without Catheter

Role: lead

NCT04055636Unknown

Observational Trial of Cardiotoxicity in Patients Undergoing Chemotherapy.

Role: lead

NCT04511689Unknown

Comparative Study of Gene-activated Bone Substitute and Xenogenic Bone Matrix in Alveolar Ridge Augmentation

Role: collaborator

NCT04380376Phase 2Unknown

Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia

Role: collaborator

NCT04278040Phase 2Unknown

Inhalations of Ultra-low Doses of Melphalan for the Treatment of Non-cystic Fibrosis Bronchiectasis

Role: collaborator

NCT04137029Not ApplicableUnknown

Methacholine, Long-acting M-cholinolytic and beta2-agonist on the Activity of Beta-receptors in Healthy Volunteers

Role: collaborator

NCT04101279Not ApplicableUnknown

Midurethral Synthetic Tape With Tension Control Mechanism Versus Midurethral Free Tape

Role: lead

NCT03076138Not ApplicableCompleted

Gene-activated Bone Substitute for Maxillofacial Bone Regeneration

Role: collaborator

NCT02293031Not ApplicableUnknown

Gene-activated Matrix for Bone Tissue Repair in Maxillofacial Surgery

Role: collaborator

NCT01872299Completed

Studies Investigating Co-morbidities Aggravating Heart Failure

Role: collaborator